期刊文献+

正常中国汉人及精神分裂症患者红细胞COMT活性分析 被引量:1

Erythrocytes catechol-O-methyltransferase activity in normal Chinese Han people and patients with schizophrenia
下载PDF
导出
摘要 目的:分析红细胞COMT活性与精神分裂症的关系,探讨精神分裂症发病的生化机制。方法:采用高效液相色谱法测定112例精神分裂症患者和116例健康正常人红细胞中COMT的活性,用SPSS统计软件对测定结果进行检验比较。结果:患者组与对照组年龄差异无显著性(P>0.05),患者组男女之间、对照组男女之间COMT活性差异也无显著性(P>0.05),COMT活性频率分布患者组在4.5~26.3nmol/ml RBC/hr范围,对照组为7.2~28.3 nmol/ml RBC/hr范围。患者组COMT平均活性为(12.2±4.0)nmol/ml RBC/hr,对照组COMT平均活性为(16.6±3.7)nmol/ml RBC/hr。男性患者为(12.3±3.8)nmol/ml RBC/hr,女性患者为(11.6±4.0)nmol/ml RBC/hr,对照组男性为(16.5±4.5)nmol/ml RBC/hr,女性为(15.3±3.9)nmol/ml RBC/hr,患者组和对照组及男、女性患者和男、女性对照者之间,COMT活性的差异均具非常显著性(P<0.001)。结论:精神分裂症患者红细胞COMT活性显著低于正常人,提示低活性COMT基因与精神分裂症关联。 Objective:To analyze the relationship between catechol - O - methyltransferase (COMT) activity and schizophrenia. To explore the biological mechanism of the etiology of schizophrenia. Methods:The activities of 112 schizophrenia and 116 normal control were measured with high performance liquid chromatography, all examined data were tested by SPSS 11.0v. Results : There was no significant difference between patients group and control group in sex and age ( p 〉 0.05 ), and no difference between male and female group in COMT activity. COMT activity frequency distribution of patients group and control group are at the range of 4.5. - 26. 3nmol/ml RBC/hr and 7.2 -28.3nmol/ml RBC/hr separately. The average activity of COMT in patients group and control group were 12.20 ± 4.0nmol/ml RBC/hr and 16.6 ± 3.7nmol/ml RBC/hr representatively. COMT activity in male and female patient were 12.3 ± 3.8nmol/ml RBC/hr and 11.6 ± 4.0nmol/ml RBC/hr. , male and female control group were 16.5 ± 4.5nmol/ml RBC/hr and 15.3 ±3.9nmol/ml RBC/hr, there were significant difference between patients group and control group and also between male and female (P 〈0. 001 ). Conclusions: The activity of COMT in affective disorders red cells is lower than normal population and suggested that the lower COMT activity of erythrocytes associated with schizophrenia.
出处 《中国民康医学》 2007年第11期419-420,424,共3页 Medical Journal of Chinese People’s Health
基金 深圳市科技局科技三项经费资助项目(199904065 200104082)
关键词 精神分裂症 红细胞 儿茶酚氧位甲基转移酶 活性 Schizophrenia Erythrocyte Catechol- O- methyltransferase Activity
  • 相关文献

参考文献10

  • 1Gershon ES,Jonas WZ.Erythrocyte soluble catechol-O-methytransferase activity in primary affective disorder.A clinical and genetic study[J].Arch Gen Psychiatry,1975,32(11):1351-1356.
  • 2Karege F,Bovier P,Gaillard JM,et al.The decrease of erythrocyte catechol-O-methytransferase activity in depressed patients and diagnostic significance[J].Acta Psychiatr scand,1987,76(3):303-308.
  • 3White HL,McLeod MN,Davidson JR.Catechol O-methyltransferase in red blood cells of schizophrenic,depressed,and normal human subjects[J].Br J Psychiatry,1976,128:184-187.
  • 4闫小华,邓小敏,吴怀安.高效液相色谱法测定人体红细胞中儿茶酚氧位甲基转移酶的活性[J].色谱,2001,19(3):230-232. 被引量:5
  • 5Kankkola S,Gordin A,Mannisto PT.General properties and clinical possibilities of new selective inhibitor of catechol-O-methytransferase[J].Gen Pharmacol,1994,25:813-824.
  • 6Floderus Y,Ross SB,Wetterberg L.E.Erythrocyte catechol-O-methytransferase activity in a Swedish population[J].Clin Genet,1981,19:389-392.
  • 7Daniels JK,Williams NM,Williams J,et al.No evidence for allelic association between schizophrenia and a polymorphism deteming high or low catechol-O-methytransferase activity[J].Am J Psychiatry,1996,153:268-270.
  • 8Herbert M,Lachman MD,Karen AN,et al.Association between catechol-O-methytransferase genotype and violence in schizophrenia and schizoaffective disorder[J].Am J Psychiatry,1998,155:835-837.
  • 9张野,江三多,钱伊萍,李飞,汪栋祥,汤国梅,江开达.情感性精神障碍与儿茶酚邻位甲基转移酶基因的关联性研究[J].中华精神科杂志,2002,35(4):206-208. 被引量:7
  • 10吴怀安,邓小敏,闫小华,刘铁榜,沈其杰.儿茶酚氧位甲基转移酶基因多态性与心境障碍的关联研究[J].中华精神科杂志,2003,36(2):65-68. 被引量:4

二级参考文献14

  • 1郭政 李霞 李品 编著.现代分子生物学与基因组信息学[M].沈阳:黑龙江科学技术出版社,1998.239-245.
  • 2沈渔Cun 主编.精神病学第3版[M].北京:人民卫生出版社,1995.576-578.
  • 3Floderus Y, Boss SB, Wetterberg L. Erythrocyte catechol-Omethyltranderase activity in a Swedish population. Clin Genet, 1981,19:389-392.
  • 4Kaakkola S, Gordin A, Mannisto PT. General properties and clinical possibilities of new selective inhibitors of catechol Omethyltransferase. Gen Pharmacol, 1994, 25:813-824.
  • 5Tenhtmen J, Saiminen M, Lundstrom K, et aL Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem, 1994, 223:1049-1059.
  • 6Bertocci B, Miggiano V, Da Prada M, et al. Human calechol-O-methyltransferase: cloning and expression of the membrane-associated form. Proc Natl Acad Sci U S A. 1991.88:1416-1420.
  • 7Papolos DF, Faedda GL, Veit S, et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry, 1996, 153:1541-1547.
  • 8Kirov G, Murphy KC, Arranz MJ, et al. Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Mol Psychiatry, 1998, 3 : 342-345.
  • 9Karege F, Bovier P, Gainard JM, et al. The decrease of erythrocyte catechol-O-methyltransferase activity in depressed patients and its diagnostic significance. Acta Psychiatr Scand, 1987, 76:303-308.
  • 10Ohara K, Nagai M, Suzuki Y, et al. Low activity allele of ctaechol-O-methyltransferase gene and Japanese unipolar depression. Neuroreport,1998, 9:1305-1308.

共引文献9

同被引文献12

  • 1闫小华,吴怀安,邓小敏,沈其杰,张宏久,周凡,刘仁刚.抑郁症患者红细胞儿茶酚氧位甲基转移酶活性的研究[J].中华精神科杂志,2005,38(3):154-156. 被引量:9
  • 2XIE T,HO S L,RAMSDEN D.Characterization and implications of estrogenic down-regulation of human catechoI-O-methyltransferase gene transcription[J].Mol Pharmacol,1999,56(1):31-38.
  • 3M(A)NNIST(O) P T,KAAKKOLA S.CatechoI-O-methyltransferase (COMT):biochemistry,molecular biology,pharmacology,and clinical efficacy of the new selective COMT inhibitors[J].Pharmacol Rev,1999,51 (4):593-628.
  • 4COTTON N J,STODDARD B,PARSON W W.Oxidative inhibition of human soluble catechol-O-methyltransferase[J].J Biol Chem,2004,279(22):23710-23718.
  • 5HIRATA H,HINODA Y,OKAYAMA N,et al.COMT polymorphisms affecting protein expression are risk factors for endometrial cancer[J].Mol Carcinog,2008,47(10):768-774.
  • 6BERSTEIN L M,ZIMARINA T S,TSYRLINA E V,et al.Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system[J].Vopr Onkol,2004,50(2):169-173.
  • 7BONIF(A)CIO M J,PALMA P N,ALMEIDA L,et al.CatechoI-O-methyltransferase and Its Inhibitors in Parkinson's disease[J].CNS Drug Rev,2007,13(3):352-379.
  • 8PIHLAVlSTO P,REENIL(A) I.Separation methods for catechoI-O-ethyltransferase activity assay:physiological and pathophysiological relevance[J].J Chromatogr B Analyt Technol Biomed Life Sci,2002,781 (1-2):359-372.
  • 9LACHMAN H M,PAPOLOS D F,SAITO T,et al.Human catechoI-O-methyltransferase pharmacogenetics:description of a functional polymorphism and its potential application to neuropsychiatric disorders[J].Pharmacogenetics,1996,6(3):243-250.
  • 10WEISZ J,FRITZ-WOLZ G,CLAWSON G A,et al.Induction of nuclear catechol-O-methyltransferase by estrogens in hamster kidney:implications for estrogen-induced renal cancer[J].Carcinogenesis,1998,19(7):1307-1312.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部